Skip to main content

StrainX Bioworks

Category: AI in Biotech / Drug Discovery

India-based synthetic biology and precision fermentation startup producing alternative proteins and high-value food ingredients at scale. StrainX Bioworks was founded in 2023. The company is led by Akshay Mittal. Based in Bhopal, Madhya Pradesh, India. Team size: 51-200. Total funding raised: $13M. Latest round: Venture Round. Key investors include Prime Venture Partners; Leo Capital; Good Startup; Sparrow Capital; Sun Icon Ventures; Dholakia Ventures; WindT Angels (IIT Delhi alumni fund).

Founded
2023
Headquarters
Bhopal, Madhya Pradesh, India
Team size
51-200
Total funding
$13M

Value proposition

Full-stack precision fermentation platform that engineers microbes to produce alternative proteins and high-value bioengineered ingredients for food, nutrition, cosmetics, and materials — with a cost advantage from India-based manufacturing.

Products and solutions

Precision-fermented alternative proteins and high-value food/nutritional ingredients (first molecule self-affirmed GRAS in US; second molecule in pipeline). B2B ingredient supply model with application development and formulation support.

Unique value

Full-stack, in-house precision fermentation platform (strain engineering → scale-up → manufacturing → commercialization) built in India with 3-4x capital efficiency vs Western peers; verified 10,000L runs; modular path to 100,000L; US GRAS clearance already secured.

Target customer

Global food & beverage companies, ingredient distributors, and food brands seeking sustainable, animal-free protein and functional ingredients.

Industries served

Food & Beverage; Nutrition; Cosmetics & Personal Care; Materials

Technology advantage

Integrated platform spanning molecular biology, strain engineering, protein engineering, metabolic engineering, computational biology, and precision fermentation. 10,000L demonstration-scale facility in Bhopal with modular design for 100,000L scale-up. India-based manufacturing at 1/3 to 1/4 the cost of US/Europe. 100+ person team including 15 PhDs.

How they differentiate

Full-stack in-house approach (vs CDMO-dependent peers); India-based manufacturing cost advantage (3-4x cheaper than US/Europe); already demonstrated 10,000L scale with verified repeatable runs; US regulatory clearance secured; platform model (not single-product) targeting multiple molecules across food, nutrition, and adjacent categories.

Main competitors

Zero Cow Factory (India); Phyx44 Labs (India); Iuva Labs (India); Perfect Day (US); Remilk (Israel)

Key partnerships

Engaging with 20-30 global food & beverage companies for supply partnerships; US FDA self-GRAS determination for first molecule

Major milestones

2023: Company founded; 2024-2026: Stealth mode — built 100+ person team, 10,000L facility, secured US self-GRAS for first molecule; May 2026: Emerged from stealth with $13M funding round

Growth metrics

100+ employees (35 scientists, ~15 PhDs); 10,000L fermentation capacity operational; scaling to 100,000L over 12-18 months; 20-30 global F&B companies in partnership discussions

Market positioning

Early-stage but operationally advanced precision fermentation platform positioning India as a global biomanufacturing hub. One of the largest private food-tech funding rounds in India's precision fermentation space.

Geographic focus

India (primary manufacturing base); US (initial commercial market via GRAS clearance); global food & beverage markets

About Akshay Mittal

Ex-BCG (Boston Consulting Group); IIT Delhi alumnus. Previously founded First Coffee Ventures, Sagar Nutriments, Picante Mexican Grill.

Official website: